XML 50 R22.htm IDEA: XBRL DOCUMENT v3.19.2
Note 7 - Stockholders' Equity (Tables)
12 Months Ended
Jun. 30, 2019
Notes Tables  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]
   
Weighted
Average,
June 30,
2019
 
 
Range,
June 30,
2019
 
Weighted
Average,
June 30,
2018
 
 
Range,
June 30,
2018
Volatility
 
68%
 
58%
-
76%
 
74%
 
68%
-
75%
Dividend yield
 
-
 
 
-
 
 
-
 
 
-
 
Risk-free interest rate
 
2.34%
 
1.92%
-
2.78%
 
2.44%
 
1.75%
-
2.64%
Expected term (years)
 
4.1
 
1.9
to
4.6
 
5
 
3
-
6
Share-based Payment Arrangement, Option, Activity [Table Text Block]
   
 
 
 
 
Options
   
 
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life
   
 
 
Aggregate
Intrinsic
Value
 
Outstanding at July 1, 2017
   
4,545,097
    $
1.42
     
2.9
    $
176,575
 
Granted
   
2,647,500
     
0.76
     
 
     
 
 
Exercised
   
-
     
-
     
 
     
 
 
Forfeited
   
-
     
-
     
 
     
 
 
Expired
   
(365,312
)    
2.35
     
 
     
 
 
Outstanding at June 30, 2018
   
6,827,225
    $
1.11
     
3.8
    $
-
 
Granted
   
655,000
     
0.74
     
 
     
 
 
Exercised
   
-
     
-
     
 
     
 
 
Forfeited
   
-
     
-
     
 
     
 
 
Expired
   
(70,625
)    
1.26
     
 
     
 
 
Outstanding at June 30, 2019
   
7,411,600
    $
1.08
     
3.1
    $
20,375
 
Exercisable at June 30, 2019
   
7,411,600
    $
1.08
     
3.1
    $
20,375
 
Schedule of Nonvested Share Activity [Table Text Block]
   
 
 
Options
   
Weighted Average
Grant-Date Fair
Value
 
Nonvested at July 1, 2018
   
-
    $
-
 
Granted
   
655,000
     
0.36
 
Vested
   
(655,000
)    
0.36
 
Nonvested at June 30, 2019
   
-
    $
-
 
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]
   
Year
ended
June 30,
2019
   
Year
ended
June 30,
2018
 
General and administrative:
               
Fair value of stock bonuses expensed
  $
-
    $
8,723
 
Change in fair value from modification of option terms
   
211,185
     
243,761
 
Change in fair value from modification of warrant terms
   
118,233
     
163,956
 
Fair value of stock options expensed
   
206,525
     
782,135
 
Total
  $
535,943
    $
1,198,575
 
                 
Research and development:
               
Fair value of stock bonus expensed
  $
-
    $
15,098
 
Change in fair value from modification of option terms
   
11,115
     
105,895
 
Change in fair value from modification of warrant terms
   
44,793
     
132,896
 
Fair value of stock options expensed
   
29,575
     
587,215
 
Total
  $
85,483
    $
841,104